Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
38.01
-0.57 (-1.48%)
Jul 15, 2025, 4:00 PM - Market closed
Cytokinetics Market Cap
Cytokinetics has a market cap or net worth of $4.54 billion as of July 15, 2025. Its market cap has decreased by -13.94% in one year.
Market Cap
4.54B
Enterprise Value
4.51B
1-Year Change
-13.94%
Ranking
Category
Stock Price
$38.01
Market Cap Chart
Since July 16, 2020, Cytokinetics's market cap has increased from $1.76B to $4.54B, an increase of 158.49%. That is a compound annual growth rate of 20.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 4.57B | -17.42% |
| Dec 31, 2024 | 5.54B | -33.07% |
| Dec 29, 2023 | 8.27B | 90.65% |
| Dec 30, 2022 | 4.34B | 11.98% |
| Dec 31, 2021 | 3.87B | 161.87% |
| Dec 31, 2020 | 1.48B | -15.76% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.83B |
| Johnson & Johnson | 373.35B |
| AbbVie | 329.24B |
| Novo Nordisk | 299.09B |
| UnitedHealth Group | 264.62B |
| Novartis AG | 234.87B |
| Abbott Laboratories | 228.77B |
| AstraZeneca | 217.99B |